BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29675458)

  • 1. Bioengineered Liver Models for Drug Testing and Cell Differentiation Studies.
    Underhill GH; Khetani SR
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):426-439.e1. PubMed ID: 29675458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-D culture and endothelial cells improve maturity of human pluripotent stem cell-derived hepatocytes.
    Ardalani H; Sengupta S; Harms V; Vickerman V; Thomson JA; Murphy WL
    Acta Biomater; 2019 Sep; 95():371-381. PubMed ID: 31362140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.
    Davidson MD; Kukla DA; Khetani SR
    Integr Biol (Camb); 2017 Aug; 9(8):662-677. PubMed ID: 28702667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of human iPSC-derived hepatocyte phenotype via extracellular matrix microarrays.
    Monckton CP; Brougham-Cook A; Underhill GH; Khetani SR
    Acta Biomater; 2022 Nov; 153():216-230. PubMed ID: 36115650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfabrication of liver and heart tissues for drug development.
    Brown GE; Khetani SR
    Philos Trans R Soc Lond B Biol Sci; 2018 Jul; 373(1750):. PubMed ID: 29786560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro.
    Berger DR; Ware BR; Davidson MD; Allsup SR; Khetani SR
    Hepatology; 2015 Apr; 61(4):1370-81. PubMed ID: 25421237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells.
    Baze A; Parmentier C; Hendriks DFG; Hurrell T; Heyd B; Bachellier P; Schuster C; Ingelman-Sundberg M; Richert L
    Tissue Eng Part C Methods; 2018 Sep; 24(9):534-545. PubMed ID: 30101670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cell Culture Platform to Maintain Long-term Phenotype of Primary Human Hepatocytes and Endothelial Cells.
    Ware BR; Durham MJ; Monckton CP; Khetani SR
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):187-207. PubMed ID: 29379855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically inspired culture medium prolongs the lifetime and insulin sensitivity of human hepatocytes in micropatterned co-cultures.
    Davidson MD; Pickrell J; Khetani SR
    Toxicology; 2021 Feb; 449():152662. PubMed ID: 33359713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver-Chip for the Study of Drug-Induced Liver Injury.
    Shi Q; Arefin A; Ren L; Papineau KS; Barnette DA; Schnackenberg LK; Hawes JJ; Avigan M; Mendrick DL; Ewart L; Ronxhi J
    Curr Protoc; 2022 Jul; 2(7):e478. PubMed ID: 35790095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in Three-Dimensional Models.
    Kukla DA; Crampton AL; Wood DK; Khetani SR
    Gene Expr; 2020 Jun; 20(1):1-18. PubMed ID: 32290899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
    Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
    Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges for the Applications of Human Pluripotent Stem Cell-Derived Liver Organoids.
    Chang M; Bogacheva MS; Lou YR
    Front Cell Dev Biol; 2021; 9():748576. PubMed ID: 34660606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury.
    Lin C; Khetani SR
    Biomed Res Int; 2016; 2016():1829148. PubMed ID: 27725933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative transcriptomic and phenotypic analysis of induced pluripotent stem cell hepatocyte-like cells and primary human hepatocytes.
    Gandhi N; Wills L; Akers K; Su Y; Niccum P; Murali TM; Rajagopalan P
    Cell Tissue Res; 2024 Apr; 396(1):119-139. PubMed ID: 38369646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of engineered liver tissues for novel drug discovery.
    Lin C; Ballinger KR; Khetani SR
    Expert Opin Drug Discov; 2015 May; 10(5):519-40. PubMed ID: 25840592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro.
    Kammerer S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-Dimensional Spheroids With Primary Human Liver Cells and Differential Roles of Kupffer Cells in Drug-Induced Liver Injury.
    Li F; Cao L; Parikh S; Zuo R
    J Pharm Sci; 2020 Jun; 109(6):1912-1923. PubMed ID: 32145211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.